DELZICOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Delzicol, and when can generic versions of Delzicol launch?
Delzicol is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in DELZICOL is mesalamine. There are twenty-eight drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the mesalamine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Delzicol
A generic version of DELZICOL was approved as mesalamine by PADAGIS ISRAEL on September 17th, 2004.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DELZICOL?
- What are the global sales for DELZICOL?
- What is Average Wholesale Price for DELZICOL?
Summary for DELZICOL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 181 |
Clinical Trials: | 2 |
Patent Applications: | 4,392 |
Drug Prices: | Drug price information for DELZICOL |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DELZICOL |
What excipients (inactive ingredients) are in DELZICOL? | DELZICOL excipients list |
DailyMed Link: | DELZICOL at DailyMed |
Recent Clinical Trials for DELZICOL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
AbbVie | Phase 3 |
Holy Stone Healthcare Co., Ltd | Phase 1 |
Pharmacology for DELZICOL
Drug Class | Aminosalicylate |
Paragraph IV (Patent) Challenges for DELZICOL
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
DELZICOL | Delayed-release Capsules | mesalamine | 400 mg | 204412 | 1 | 2014-06-17 |
US Patents and Regulatory Information for DELZICOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DELZICOL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | DELZICOL | mesalamine | CAPSULE, DELAYED RELEASE;ORAL | 204412-001 | Feb 1, 2013 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DELZICOL
See the table below for patents covering DELZICOL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
United Kingdom | 8322387 | ⤷ Sign Up | |
Italy | 1149328 | COMPOSIZIONE FARMACEUTICA PER LA SOMMINISTRAZIONE PER VIA ORALE DI COMPOSTI CHE DEBBONO ESSERE ASSORBITI NELL'INTESTINO CRASSO | ⤷ Sign Up |
Canada | 1172570 | COMPOSES PHARMACEUTIQUES ADMINISTRES PAR VOIE ORALE (ORALLY ADMINISTRABLE PHARMACEUTICAL COMPOSITIONS) | ⤷ Sign Up |
Finland | 85216 | ⤷ Sign Up | |
South Korea | 100536084 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |